Concepedia

Duncan I. Mackie

DI

Statistics

Publications

9

Citations

258

H-Index

9

Active since

2011

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Iowa

University of Iowa Hospitals and Clinics

Aston University

University of Cambridge

Duncan I. Mackie is an author at University of North Carolina at Chapel Hill specializing in molecular pharmacology, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2021

9

Publications

9

RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis

Duncan I. Mackie, Natalie R. Nielsen, Matthew Harris et al. · Proceedings of the National Academy of Sciences · 2019 · 52 citations · Full text

RGS17: An Emerging Therapeutic Target for Lung and Prostate Cancers

Christopher Bodle, Duncan I. Mackie, David L. Roman · Future Medicinal Chemistry · 2013 · 46 citations · Full text

, , +21

h<i>CALCRL</i> mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia

Duncan I. Mackie, Fuad Al Mutairi, Reema B. Davis et al. · The Journal of Experimental Medicine · 2018 · 37 citations · Full text

A High Throughput Screen for RGS Proteins Using Steady State Monitoring of Free Phosphate Formation

C. Aaron Monroy, Duncan I. Mackie, David L. Roman · PLoS ONE · 2013 · 31 citations · Full text

, , +22

Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines

Christopher Bodle, Duncan I. Mackie, Michael P. Hayes et al. · Journal of Natural Products · 2017 · 25 citations · Full text

Rows per page

1–5 of 9